Australia Expands Access to MDMA and Psilocybin Therapies Under New TGA Framework
VANCOUVER, British Columbia, May 29, 2026 Optimi Health Corp. has welcomed new recommendations issued by Australia’s Therapeutic Goods Administration...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
VANCOUVER, British Columbia, May 29, 2026 Optimi Health Corp. has welcomed new recommendations issued by Australia’s Therapeutic Goods Administration...
MONTREAL, Canada, May 29, 2026 Leica Biosystems, a global leader in anatomic and digital pathology solutions, and CellCarta, a...
CHICAGO, Ill., May 29, 2026 Cardiosense has achieved a major regulatory milestone with the U.S. Food and Drug Administration...
CHICAGO, IL – November 11, 2025 — Scientists at Northwestern University Feinberg School of Medicine have developed a novel...
